Utilization of Sleep Pulse Oximetry in Fibromyalgia Patients

Overview

About this study

The purpose of this study is to evaluate the utilization of the sleep pulse oximeter test for fibromyalgia patients based on the Berlin and STOP-BANG survey results. The aim is to enhance individualized medicine testing for fibromyalgia patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients diagnosed with FM at our Fibromyalgia Clinic
  • Patients actively being seen at the Fibromyalgia Clinic
  • FM patients age 18-75
  • Able and willing to give informed consent
  • Able to speak English
  • Able to complete questionnaires

Exclusion Criteria:

  • Diagnoses of bipolar disorder, schizophrenia, or dementia
  • Individuals who decline to participate in the study

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Arya Mohabbat, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20391199

Mayo Clinic Footer